Skip to Main Content

Author Details

Michael P Busch
Vitalant Research Institute
1983
759
92
PMIDPaper TitleJournal TitlePublished Year
37976448Regulation of kynurenine metabolism by blood donor genetics and biology impacts red cell hemolysis in vitro and in vivo.Blood2024
38054619Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS-CoV-2 infection and vaccination.Transfusion2024
36484950Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors.Cell Tissue Bank2023
37512500Red Blood Cell Metabolism In Vivo and In Vitro.Metabolites2023
37494421Assessment of stored red blood cells through lab-on-a-chip technologies for precision transfusion medicine.Proc Natl Acad Sci U S A2023
35687888Surveillance for Zika, Chikungunya, and Dengue Virus Incidence and RNAemia in Blood Donors at 4 Brazilian Blood Centers During 2016-2019.J Infect Dis2023
37126090Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary.AIDS Res Hum Retroviruses2023
37024253Monitoring SARS-CoV-2 incidence and seroconversion among university students and employees: a longitudinal cohort study in California, June-August 2020.BMJ Open2023
37119030SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency.Am J Epidemiol2023
37250174Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras.Open Forum Infect Dis2023
37414788Application of ultrasensitive digital ELISA for p24 enables improved evaluation of HIV-1 reservoir diversity and growth kinetics in viral outgrowth assays.Sci Rep2023
37347180Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications.Microbiol Spectr2023
37262007Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022.MMWR Morb Mortal Wkly Rep2023
36695358Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.AIDS2023
36621777Plasma transfusion-transmission of Zika virus in mice and macaques.Transfusion2023
36469038Sphingosine 1-phosphate has a negative effect on RBC storage quality.Blood Adv2023
36712077Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection.bioRxiv2023
36930653Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood screening.PLoS Negl Trop Dis2023
34111244Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.Clin Infect Dis2022
35443018Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation.PLoS Pathog2022
35508478Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2.Nat Commun2022
35441384The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.Transfusion2022
35612315Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.Microbiol Spectr2022
35834347Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma.J Clin Invest2022
35607854How do we⿦form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?Transfusion2022
35726756Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reduction.Transfusion2022
35696249Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.JAMA2022
35819428Clinical Protection During the First Omicron Wave in Unvaccinated, Convalescent US Adults.JAMA2022
35815724Four decades of HIV and transfusion safety: Much accomplished but ongoing challenges.Transfusion2022
35684974Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021.Clin Infect Dis2022
35684973Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.Clin Infect Dis2022
36962725Health inequities in SARS-CoV-2 infection, seroprevalence, and COVID-19 vaccination: Results from the East Bay COVID-19 study.PLOS Glob Public Health2022
36146515Predicting SARS-CoV-2 Variant Spread in a Completely Seropositive Population Using Semi-Quantitative Antibody Measurements in Blood Donors.Vaccines (Basel)2022
36366424Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection.Viruses2022
36135358SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study.Elife2022
35959415Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study.Lancet Reg Health Eur2022
36298818Efficacy of Different Testing Scenarios in Reducing Transfusion-Transmitted Hepatitis B Virus (TT-HBV) Infection Risk.Viruses2022
35891406The Impact of Early Antiretroviral Treatment (ART) for HIV on the Sensitivity of the Latest Generation of Blood Screening and Point of Care Assays.Viruses2022
35921537Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States Before the Delta- and Omicron-Associated Surges: A Retrospective Cohort Study of Repeat Blood Donors.J Infect Dis2022
36054476Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patients.Transfusion2022
36395887Genome-wide metabolite quantitative trait loci analysis (mQTL) in red blood cells from volunteer blood donors.J Biol Chem2022
35289071Quantitative restoration of immune defense in old animals determined by naive antigen-specific CD8 T-cell numbers.Aging Cell2022
35129839Vaccination of COVID-19 convalescent plasma donors increases binding and neutralizing antibodies against SARS-CoV-2 variants.Transfusion2022
35128658Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment.Transfusion2022
35285520Reprogramming of red blood cell metabolism in Zika virus-infected donors.Transfusion2022
35123418Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil.BMC Infect Dis2022
35090584Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1.Am J Hum Genet2022
35202525Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications.Emerg Infect Dis2022
35236896Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict Study.Sci Rep2022
35296773Author Correction: Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict Study.Sci Rep2022
  • 1 - 50 of 759

Recommended Authors

University of Texas Southwestern Medical Center
Career Start Year 2018
Number of shared co-authors 2
Veterans Affairs Connecticut Healthcare System
Career Start Year 2014
Number of shared co-authors 10
Division of Clinical Microbiology, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 4
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 3
Emory University School of Medicine
Career Start Year 2009
Number of shared co-authors 6
University of Washington
Career Start Year 2007
Number of shared co-authors 6
Yale University School of Medicine, Yale-New Haven Hospital
Career Start Year 2007
Number of shared co-authors 16
Goethe University Frankfurt, University Hospital
Career Start Year 2003
Number of shared co-authors 1
Children's National Hospital
Career Start Year 2003
Number of shared co-authors 20
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 8
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 22
Clarkson University
Career Start Year 1999
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 0
RAND Corporation
Career Start Year 1995
Number of shared co-authors 8
Albany Medical Center Hospitalgrid.413558.e
Career Start Year 1991
Number of shared co-authors 1
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 5
Mount Sinai Health System and University Health Network
Career Start Year 1989
Number of shared co-authors 5
Washington University School of Medicine
Career Start Year 1988
Number of shared co-authors 14
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 1
VA Medical Center
Career Start Year 1986
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 10
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 0
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 5
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 13
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 16
Italian Ministry of Health
Career Start Year 1977
Number of shared co-authors 5
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 2
NYU Grossman School of Medicine
Career Start Year 1975
Number of shared co-authors 1
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 6
University of Alabama at Birmingham
Career Start Year 1972
Number of shared co-authors 14

Collaborators

University of British Columbia
Co-authored papers 125
Vitalant Research Institute
Co-authored papers 93
Co-authored papers 79
Scientific Services
Co-authored papers 63
Vitalant Research Institute
Co-authored papers 58
Clinical Sciences
Co-authored papers 49
University of California San Francisco
Co-authored papers 37
University of California san francisco
Co-authored papers 36
Cerus Corporation
Co-authored papers 36
Co-authored papers 27
Co-authored papers 23
Genomics and Translational Research Center
Co-authored papers 22
Co-authored papers 19
Clinical Services
Co-authored papers 18
Vitalant Research Institute
Co-authored papers 18
University of Colorado Anschutz Medical Campus
Co-authored papers 17
University of Pittsburgh
Co-authored papers 16
Co-authored papers 16
University of Virginia
Co-authored papers 15
Co-authored papers 15
Yale University
Co-authored papers 15
University of California san francisco
Co-authored papers 15
GeneCentric Therapeutics Inc.
Co-authored papers 12
Co-authored papers 12
Co-authored papers 12
Johns Hopkins University
Co-authored papers 11
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 11
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 11
Johns Hopkins University
Co-authored papers 10
University of Maryland School of Medicine
Co-authored papers 10